VCYT (Veracyte) Cash Payments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VCYT Veracyte Inc VCYT
75 GF Score
Price $59.40
GF Value $38.30
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Veracyte Cash Payments?

Cash Payments only applicable to companies reporting Cash Flow from Operations in direct method.

VCYT
75GF Score
Veracyte Inc VCYT
Cash Payments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Veracyte (VCYT) Overvalued in 2026?

Based on GuruFocus' analysis, Veracyte stock appears to be overvalued. The current stock price of $59.40 is trading 55.1% above its estimated GF Value™ of $38.30. GuruFocus considers Veracyte to be Significantly Overvalued.

Key valuation signals for VCYT:

  • Cash Payments:
  • GF Value™: $38.30 vs. price of $59.40 (55.1% above fair value)
  • GF Score™: 75/100 with 7 warning signs

No single metric tells the full story. See the VCYT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Veracyte Business Description

Other Exchanges 12V:Germany
Address 6000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
75GF Score

Get the complete analysis for VCYT

Cash Payments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$59.40
Price
$38.30
GF Value